These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1467 related items for PubMed ID: 16957146

  • 1. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 2. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.
    Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016
    [Abstract] [Full Text] [Related]

  • 3. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.
    N Engl J Med; 2004 Feb 12; 350(7):672-83. PubMed ID: 14764923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.
    Staff AC, Harsem NK, Braekke K, Hyer M, Hoover RN, Troisi R.
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar 12; 143(1):29-33. PubMed ID: 19135290
    [Abstract] [Full Text] [Related]

  • 7. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Moore Simas TA.
    Am J Obstet Gynecol; 2013 Jul 12; 209(1):53.e1-9. PubMed ID: 23517919
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK, Chandel N, Jain V, Jha V.
    J Hum Hypertens; 2012 Apr 12; 26(4):236-41. PubMed ID: 21451568
    [Abstract] [Full Text] [Related]

  • 11. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.
    J Matern Fetal Neonatal Med; 2014 Jul 12; 27(10):1038-48. PubMed ID: 24066977
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
    Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.
    PLoS One; 2010 Oct 11; 5(10):e13263. PubMed ID: 20948996
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL.
    J Rheumatol; 2015 Jul 11; 42(7):1141-9. PubMed ID: 25979720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV.
    Am J Obstet Gynecol; 2008 Sep 11; 199(3):266.e1-6. PubMed ID: 18771978
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
    Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.
    Am J Obstet Gynecol; 2013 Apr 11; 208(4):287.e1-287.e15. PubMed ID: 23333542
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.